Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer
2018 · Scientific Reports · 55 citations
https://doi.org/10.1038/s41598-018-33190-8
M
Masaru Matsumoto
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
258
Papers
3.1K
Citations
29
h-index
78
i10-index
Masaru Matsumoto is an academic researcher from Ishikawa Prefectural Nursing University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Zeolite Catalysis and Synthesis & Pelvic floor disorders treatments. The author has an h-index of 29, co-authored 220 publications.
ORCID: 0000-0003-0246-395XPapers by this author
worksMET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation
2015 · BMC Cancer · 32 citations
https://doi.org/10.1186/s12885-015-1019-1
Establishing a Methodology for Ultrasound Evaluation of Pharyngeal Residue in the Pyriform Sinus and Epiglottic Vallecula
2019 · Respiratory Care · 21 citations
https://doi.org/10.4187/respcare.07002
Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
2015 · BMC Research Notes · 12 citations
https://doi.org/10.1186/s13104-015-1126-8
Differential gene expression analysis and SNP/InDel marker discovery in resistant wild Asparagus kiusianus and susceptible A. officinalis in response to Phomopsis asparagi infection
2018 · Data in Brief · 5 citations
https://doi.org/10.1016/j.dib.2018.11.034
Loop formation by an aortic occlusion balloon catheter during resuscitative endovascular balloon occlusion of the aorta (REBOA)
2018 · Radiology Case Reports · 3 citations
https://doi.org/10.1016/j.radcr.2018.10.018
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat